ECCO guidelines on therapeutics in Crohn's disease: medical treatment

H Gordon, S Minozzi, U Kopylov… - Journal of Crohn's …, 2024 - academic.oup.com
Crohn's disease [CD] is a chronic inflammatory bowel disease [IBD] that can result in
progressive bowel damage and disability. 1 CD can affect individuals of any age, from …

Dose escalation patterns of advanced therapies in Crohn's disease and ulcerative colitis: a systematic literature review

R Panaccione, WJ Lee, R Clark, K Kligys… - Advances in …, 2023 - Springer
Introduction Dose escalation is one of the treatment approaches studied and suggested in
advanced therapies for Crohn's disease (CD) and ulcerative colitis (UC). This study aimed to …

Systematic review: efficacy of escalated maintenance anti‐tumour necrosis factor therapy in Crohn's disease

VY Mattoo, C Basnayake, WR Connell… - Alimentary …, 2021 - Wiley Online Library
Background Loss of response to anti‐TNF agents is a common clinical problem. Dose
escalation may be effective for reestablishing clinical response in Crohn's disease (CD) …

[HTML][HTML] Treat to target in Crohn's disease: a practical guide for clinicians

AR Srinivasan - World Journal of Gastroenterology, 2024 - ncbi.nlm.nih.gov
A treat-to-target (T2T) approach applies the principles of early intervention and tight disease
control to optimise long-term outcomes in Crohn's disease. The Selecting Therapeutic …

De-escalation of Biologic Treatment in Inflammatory Bowel Disease: A Comprehensive Review

JP Gisbert, M Chaparro - Journal of Crohn's and Colitis, 2024 - academic.oup.com
Introduction Biologic therapy is an effective treatment for inflammatory bowel disease [IBD].
However due to cost and safety concerns, dose de-escalation strategies after achieving …

Role of digital health and artificial intelligence in inflammatory bowel disease: a sco** review

K Majidova, J Handfield, K Kafi, RD Martin, R Kubinski - Genes, 2021 - mdpi.com
Inflammatory bowel diseases (IBD), subdivided into Crohn's disease (CD) and ulcerative
colitis (UC), are chronic diseases that are characterized by relapsing and remitting periods …

Systematic review and meta-analysis: evaluating response to empiric anti-TNF dose intensification for secondary loss of response in Crohn's disease

A Srinivasan, R Gilmore… - Therapeutic …, 2022 - journals.sagepub.com
Introduction: Anti-tumor necrosis factor (TNF) dose intensification represents an effective
method of overcoming secondary loss of response (LOR); however, a subset of patients may …

Competencies of nurses to participate in safe medication management practices for biologics: A sco** review

W Li, L Li, L Li, C **aodong, M Chen, H Liu, P Li - PloS one, 2025 - journals.plos.org
Aim To review the existing literature relating to nurse competence in safe medication
management practices for biologics, identify evidence, and develop a competency …

The use of telemedicine in older patients with gastrointestinal diseases

MD Dong, S Steuwe, LA Barry, CA Siegel - Current Treatment Options in …, 2022 - Springer
Abstract Purpose of Review The COVID-19 pandemic helped us understand that
telemedicine provides an alternative way to manage patients remotely, with an added …

Past, Present, and Future: A History Lesson in Artificial Intelligence

S Enslin, V Kaul - Gastrointestinal Endoscopy Clinics, 2024 - giendo.theclinics.com
Artificial intelligence (AI) is the capability of machines to execute tasks that generally require
human intelligence. AI programs use algorithms to collect, interpret, and analyze data …